John R. Gosney

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Assessing PD-L1 expression in non-small cell lung carcinoma: a prospective study of matched fine-needle aspirates, core biopsies, and resection specimens using alcohol and forming fixatives.

Assessing PD-L1 expression in non-small cell lung carcinoma: a prospective study of matched fine-needle aspirates, core biopsies, and resection specimens using alcohol and forming fixatives.

Journal: The journal of pathology. Clinical research

Published: April 08, 2025

Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer.

Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 06, 2024

Response to letter entitled: letter comments on: Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.

Response to letter entitled: letter comments on: Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.

Journal: ESMO open

Published: October 11, 2023

Radiological-pathological correlation in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): imaging and histopathology.

Radiological-pathological correlation in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): imaging and histopathology.

Journal: Clinical radiology

Published: June 05, 2023

Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression in non-small-cell lung cancer.

Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression in non-small-cell lung cancer.

Journal: Journal of clinical pathology

Published: May 25, 2023

Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.

Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.

Journal: Journal of clinical pathology

Published: March 16, 2023

Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.

Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.

Journal: ESMO open

Published: February 14, 2023

Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions.

Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions.

Journal: Journal of clinical pathology

Published: November 07, 2022

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis.

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis.

Journal: The Lancet regional health. Europe

Published: November 22, 2021

Biomarker Testing for People With Advanced Lung Cancer in England.

Biomarker Testing for People With Advanced Lung Cancer in England.

Journal: JTO clinical and research reports

Published: January 14, 2021

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.

Journal: ESMO open

Published: October 15, 2020

Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.

Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.

Journal: British journal of cancer

Published: July 15, 2020

Showing 1-12 of 48

Last Updated: 09/26/2026